Shopping Cart
Remove All
Your shopping cart is currently empty
Sacituzumab tirumotecan (Synonyms: SKB264, SKB 264, MK-2870, MK2870)
Catalog No. T9901A-237 Copy Product Info
Purity: 99%
🥰Excellent
Sacituzumab tirumotecan (SKB264) is an antibody-drug conjugate (ADC) targeting TROP2 (trophoblast cell surface antigen 2), capable of releasing the active payload KL610023 within TROP2-positive tumour cells. an effective topoisomerase I inhibitor that induces DNA damage and leads to cell cycle arrest and apoptosis, for use in non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC).
Sacituzumab tirumotecan
Copy Product Info🥰Excellent
Catalog No. T9901A-237
Synonyms SKB264, SKB 264, MK-2870, MK2870
Sacituzumab tirumotecan (SKB264) is an antibody-drug conjugate (ADC) targeting TROP2 (trophoblast cell surface antigen 2), capable of releasing the active payload KL610023 within TROP2-positive tumour cells. an effective topoisomerase I inhibitor that induces DNA damage and leads to cell cycle arrest and apoptosis, for use in non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC).
Sacituzumab tirumotecan
Cas No. 2768350-77-0
Customer service consultation
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $358 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $918 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $1,470 | 2-4 weeks | 2-4 weeks | |
| 25 mg | $2,890 | 2-4 weeks | 2-4 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:99%
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Antigen Details
Chemical Properties
Storage & Solubility Information
| Description | Sacituzumab tirumotecan (SKB264) is an antibody-drug conjugate (ADC) targeting TROP2 (trophoblast cell surface antigen 2), capable of releasing the active payload KL610023 within TROP2-positive tumour cells. an effective topoisomerase I inhibitor that induces DNA damage and leads to cell cycle arrest and apoptosis, for use in non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC). |
| Synonyms | SKB264, SKB 264, MK-2870, MK2870 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Target | TROP-2 |
| Cas No. | 2768350-77-0 |
| Storage | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy Sacituzumab tirumotecan | purchase Sacituzumab tirumotecan | Sacituzumab tirumotecan cost | order Sacituzumab tirumotecan
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.